Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?-Reference-Cited by-同舟云学术

Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?

Published:2021-04 Issue: Volume:160 Page:103309
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Gennaro Nicolò^ORCID,Reijers Sophie^ORCID,Bruining Annemarie,Messiou Christina,Haas Rick^ORCID,Colombo Piergiuseppe,Bodalal Zuhir^ORCID,Beets-Tan Regina,van Houdt Winan,van der Graaf Winette T.A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference127 articles.

1. Serum biomarkers as prognostic factors for metastatic sarcoma;Aggerholm-Pedersen;Clin. Oncol. (R Coll. Radiol.),2019

2. Regional heterogeneity changes in DCE-MRI as response to isolated limb perfusion in experimental soft-tissue sarcomas;Alic;Contrast Media Mol. Imaging,2013

3. MR-imaging changes of musculoskeletal soft-tissue sarcomas associated with neoadjuvant chemotherapy and hyperthermia;Baur;Int. J. Hyperthermia,2003

4. Increased MR signal intensity in skeletal muscle adjacent to malignant tumors: pathologic correlation and clinical relevance;Beltran;Radiology,1987

5. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas;Benz;J. Nucl. Med.,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin;Frontiers in Pharmacology;2024-08-20

2. Parallel CNN‐Deep Learning Clinical‐Imaging Signature for Assessing Pathologic Grade and Prognosis of Soft Tissue Sarcoma Patients;Journal of Magnetic Resonance Imaging;2024-06-10

3. Évaluation de facteurs prédictifs de réponse pathologique à la radiothérapie néoadjuvante des sarcomes des tissus mous;Cancer/Radiothérapie;2023-12

4. The biology and treatment of leiomyosarcomas;Critical Reviews in Oncology/Hematology;2023-04

5. Response Evaluation of Neoadjuvant Therapies in Sarcoma;Current Treatment Options in Oncology;2023-03-28